Thursday, May 14, 2026 | 11:24 AM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch
Sohini Das

Sohini Das

Sohini Das

Sohini Das writes on automobile and healthcare sectors for Business Standard. Over her 17 years as a journalist, she has covered multiple sectors and issues -- FMCG, dairy, tourism, and state elections, among others, across Kolkata, Ahmedabad, and Mumbai. She loves doing personality stories and ground reportage.

Sohini Das writes on automobile and healthcare sectors for Business Standard. Over her 17 years as a journalist, she has covered multiple sectors and issues -- FMCG, dairy, tourism, and state elections, among others, across Kolkata, Ahmedabad, and Mumbai. She loves doing personality stories and ground reportage.

Email
Twitter
LinkedIn

Page 23 - Sohini Das

Medical tourism revenue takes a hit after govt stops visas for Bangladeshis

According to a recent CareEdge Ratings report, Bangladesh accounts for around 50-60 per cent of India's total medical tourism inflow

Medical tourism revenue takes a hit after govt stops visas for Bangladeshis
Updated On : 15 Nov 2024 | 10:59 PM IST

Hero MotoCorp Q2 results: Net profit up 5.6% on high rural demand

The consolidated revenue rose to Rs 10,482.93 crore while net profit for the quarter came in at Rs 1,063 crore

Hero MotoCorp Q2 results: Net profit up 5.6% on high rural demand
Updated On : 14 Nov 2024 | 10:22 PM IST

MG's Windsor sales in top gear, Tata Motors' EV monopoly under threat

Tata Motors said that it has 'done the maths' on the BaaS model, and is 'unconvinced' about its passenger vehicles

MG's Windsor sales in top gear, Tata Motors' EV monopoly under threat
Updated On : 13 Nov 2024 | 11:18 PM IST

Hyundai Motor India Q2 PAT down 16% in first results after listing

Carmaker's revenue falls on weak market sentiment, geopolitical factors

Hyundai Motor India Q2 PAT down 16% in first results after listing
Updated On : 12 Nov 2024 | 10:50 PM IST

After a decline, sedan segment set for action with launches lined up

Maruti launches fourth-gen Dzire; Honda to roll out new Amaze in coming months

After a decline, sedan segment set for action with launches lined up
Updated On : 12 Nov 2024 | 12:00 AM IST

Tata Motors Q2FY25 results: Net profit down 11%, revenue dips 3.5%

The stock fell 1.74 per cent on Friday to Rs 805 per share, as the company missed street estimates, which had projected a net profit of around Rs 5,000 crore

Tata Motors Q2FY25 results: Net profit down 11%, revenue dips 3.5%
Updated On : 08 Nov 2024 | 11:46 PM IST

M&M Q2FY25 results: PAT up 35% at Rs 3,171 crore on strong auto sales

Strong auto, farm growth propels automaker's revenue, with record SUV sales

M&M Q2FY25 results: PAT up 35% at Rs 3,171 crore on strong auto sales
Updated On : 07 Nov 2024 | 7:30 PM IST

Q2 result preview: 2Ws and 3Ws likely drivers of auto sector growth

Muted PV, CV sales volume in Q2 may reflect in performance of segment leaders

Q2 result preview: 2Ws and 3Ws likely drivers of auto sector growth
Updated On : 14 Oct 2024 | 11:29 PM IST

Q2 results preview: Lower input costs may aid pharma firms' margins

Analysts expect overall sales growth to be 10-11%

Q2 results preview: Lower input costs may aid pharma firms' margins
Updated On : 13 Oct 2024 | 10:42 PM IST

JCB plans to make machines 'greener' by reducing fossil fuel consumption

Has improved fuel efficiency of machines like backhoe loader by 40% in 10 years

JCB plans to make machines 'greener' by reducing fossil fuel consumption
Updated On : 11 Oct 2024 | 4:03 PM IST

'Ready to export to new electric vehicle markets if there is demand'

Unsoo Kim, president, CEO and MD, Wangdo Hur, executive director and CFO, and Tarun Garg, whole time director and COO of Hyundai Motor India outline their plans

'Ready to export to new electric vehicle markets if there is demand'
Updated On : 10 Oct 2024 | 2:13 AM IST

Auto major Hyundai sets ball rolling on India's biggest IPO at Rs 27,856 cr

The firm will be valued at Rs 1.59 trillion at the top-end of the price band of Rs 1,865-Rs 1,960

Auto major Hyundai sets ball rolling on India's biggest IPO at Rs 27,856 cr
Updated On : 10 Oct 2024 | 12:10 AM IST

Amneal Pharma to invest Rs 1,600 crore in Gujarat to make GLP-1 drugs

Globally, there is a shortage of this new class of diabetes and obesity treatment

Amneal Pharma to invest Rs 1,600 crore in Gujarat to make GLP-1 drugs
Updated On : 08 Oct 2024 | 5:15 PM IST

Glucometer maker Morepen Labs to hive off medical devices business

Expanding capacities, backward integrating production and eyeing US market for exports

Glucometer maker Morepen Labs to hive off medical devices business
Updated On : 08 Oct 2024 | 8:57 AM IST

Yulu turns Ebitda positive, aims to deploy 100K electric vehicles by 2025

With over 40,000 EVs, Yulu's revenues and users have increased more than sevenfold over the last 24 months

Yulu turns Ebitda positive, aims to deploy 100K electric vehicles by 2025
Updated On : 07 Oct 2024 | 5:44 PM IST

Festival fillip: Car dealerships see four-fold increase in footfall

Dealer sources claimed that even enquiries and bookings are up by 3-4 times when compared to the last 2-3 months

Festival fillip: Car dealerships see four-fold increase in footfall
Updated On : 06 Oct 2024 | 11:39 PM IST

BMW India targets to double electric vehicle penetration by next year

BMW Group India has achieved its best-ever year-to-date car sales, with a 10 per cent growth in the first nine months of calendar year 2024

BMW India targets to double electric vehicle penetration by next year
Updated On : 04 Oct 2024 | 11:44 PM IST

Taking stock of B'desh: Trade recovers, but Indian firms tread cautiously

The concluding part of the series highlights stabilising trade ties with Dhaka, but payment delays and a complex bilateral environment remain major concerns

Taking stock of B'desh: Trade recovers, but Indian firms tread cautiously
Updated On : 04 Oct 2024 | 11:30 PM IST

Pharmaceutical firms up their game to crackdown on spurious drugs

The concluding part of the series delves into strategies being applied by leading drug firms to battle counterfeits

Pharmaceutical firms up their game to crackdown on spurious drugs
Updated On : 03 Oct 2024 | 6:26 PM IST

Biocon Biologics refinances $1.1 bn debt through bonds, syndicated facility

Refinancing will improve liquidity and help in reinvestment, says company

Biocon Biologics refinances $1.1 bn debt through bonds, syndicated facility
Updated On : 03 Oct 2024 | 5:40 PM IST